4:44
What are the advantages of multiple myeloma maintenance therapy?
Laurent Garderet
2:28
Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
Nicolaus Kröger
2:13
Reinforcing transplantation with consolidation therapy in Hodgkin lymphoma
Anna Sureda
2:36
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?
Paul Richardson
4:05
Are we ready to use minimal residual disease (MRD) to direct multiple myeloma therapy?
Ola Landgren
4:43
Immunotherapy highlights in multiple myeloma at ASH 2016
Niels van de Donk
2:11
Temsirolimus with BERT for the treatment of relapsed mantle cell and follicular lymphoma
Georg Hess
11:19
New endpoints in clinical trials to better serve patients
Elihu H. Estey
3:21
Current therapy for CLL and the new monoclonal antibody ofatumumab
Tadeusz Robak
4:09
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Anton Hagenbeek
1:49
Trial results of idelalisib with bendamustine and rituximab in CLL
Andrew Zelenetz
1:18
Updates from current CLL clinical trials
Barbara Eichhorst
2:47
Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib
Jacqueline Barrientos
3:51
Daratumumab in multiple myeloma: an overview of 3 key trials
Niels van de Donk
3:38
Results of Phase III GADOLIN trial for follicular lymphoma
Marek Trněný
3:12
Results of Phase III POLLUX trial on daratumumab in multiple myeloma
Noopur Raje
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals